Cookson J
Royal London Hospital, London, UK.
Br J Psychiatry Suppl. 2001 Jun;41:s148-56.
Studies highlighting the difficulties associated with lithium suggest that the role of antipsychotic drugs and mood stabilizers in bipolar disorder should be reconsidered.
To review the efficacy and mode of action of antipsychotic drugs in mania, and to consider the differences between official guidelines and routine clinical practice in the use of these agents for mania.
Review of research, guideline- and practice-based literature.
Guidelines recommend lithium or valproate as first-line treatments for mania, and antipsychotic agents only as 'adjuncts' for agitation, dangerous behaviour or psychosis. However, in routine practice, antipsychotic drugs are often prescribed. The effectiveness of these agents in mania has been established by several studies; newer atypical compounds demonstrate antimanic efficacy with a reduced incidence of neurological side-effects.
Antipsychotic drugs are important in the treatment of bipolar disorder and mania. Future studies should evaluate the long-term efficacy and safety of newer atypical antipsychotic agents, and the place of anticonvulsants in combination with antipsychotics in bipolar disorder.
强调锂盐相关困难的研究表明,抗精神病药物和心境稳定剂在双相情感障碍中的作用应重新审视。
回顾抗精神病药物在躁狂发作中的疗效及作用方式,并探讨官方指南与这些药物用于躁狂发作的常规临床实践之间的差异。
对基于研究、指南及实践的文献进行综述。
指南推荐锂盐或丙戊酸盐作为躁狂发作的一线治疗药物,抗精神病药物仅作为激越、危险行为或精神病性症状的“辅助”用药。然而,在常规临床实践中,抗精神病药物常被处方使用。多项研究已证实这些药物在躁狂发作中的有效性;新型非典型化合物显示出抗躁狂疗效,且神经副作用发生率降低。
抗精神病药物在双相情感障碍和躁狂发作的治疗中很重要。未来研究应评估新型非典型抗精神病药物的长期疗效和安全性,以及抗惊厥药物与抗精神病药物联合用于双相情感障碍的地位。